Hematopoietic progenitor kinase 1 degrader - Huadong Medicine
Latest Information Update: 16 Jul 2024
At a glance
- Originator Huadong Medicine
- Class Antineoplastics
- Mechanism of Action Hematopoietic progenitor kinase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer